Objective: Several small to medium-sized studies indicated a link between cervical artery dissection (CeAD) and migraine. Migrainous CeAD patients were suggested to have different clinical characteristics compared to nonmigraine CeAD patients. We tested these hypotheses in the large Cervical Artery Dissection and Ischemic Stroke Patients (CADISP) population.
Using a case-control design, we 1) assessed whether the frequency of migraine and its subtypes (presence or absence of an aura) differs between CeAD patients with stroke and non-CeAD IS patients, matched on age and gender; and 2) compared CeAD patients with and without migraine in terms of clinical presentation, putative risk factors, and outcome in the large multicenter Cervical Artery Dissection and Ischemic Stroke Patients (CADISP) study. 9 METHODS Study population. CADISP is an international observational study focusing on research on CeAD. The structure and methods of the CADISP study have been described in detail previously. 9 The aims of CADISP are to perform a genetic association study and clinical studies on various debated topics including risk factors, clinical presentation, and outcome predictors of CeAD. Between 2004 and 2009, as part of a multicenter effort comprising 20 centers in 9 countries, we have included consecutive patients evaluated in departments of neurology with a diagnosis of CeAD. A cohort of non-CeAD IS patients, frequency-matched on age (by 5-year intervals) and gender, was recruited as controls in the same centers. The inclusion and exclusion criteria are shown in table 1. For the clinical part of the CADISP study, altogether 983 CeAD patients and 658 patients with a non-CeAD IS were recruited in 18 centers in 8 countries. For a description of CADISP centers and a flow diagram of the participant selection process see figures e-1 and e-2 on the Neurology ® Web site at www.neurology.org. NonCeAD IS patients were classified into IS subgroups according to the TOAST criteria. 10, 11 Patients were recruited both retrospectively (n ϭ 884) and prospectively (n ϭ 737). Retrospective patients are participants who had a qualifying event before the beginning of the study or were interviewed after discharge, and were identified through local registries of CeAD or IS patients in each center. Over 96% of patients had a qualifying event between 1999 and 2009 (Ͻ4% had a qualifying event before 1999), and the interviews were performed between 2004 and 2009. The detailed questionnaire included items related to symptoms of dissection and stroke; NIH Stroke Scale (NIHSS) score at admission; imaging findings of dissection and stroke; medical history such as vascular risk factors, migraine, and traumas; and follow-up data at 3 months including modified Rankin Scale (mRS) score and major complications.
Standard protocol approvals, registrations, and patient consents. The study protocol was approved by relevant local authorities in all participating centers and was conducted according to the national rules concerning ethics committee approval and informed consents.
Variable definitions. Risk factors for CeAD were defined as follows. Hypertension: a history of antihypertensive treatment or blood pressure Ն140/90 mm Hg during nonacute phase. Hypercholesterolemia: lipid-lowering treatment or total cholesterol Ն6.20 mmol/L or low-density lipoprotein cholesterol Ն4.1 mmol/L, measured within 48 hours after admission to the hospital or diagnosed by the treating physician. Diabetes: fasting glucose Ͼ7 mmol/L during nonacute phase or use of an antidiabetic therapy. Hormonal therapy: use of oral contraceptives or postmenopausal substitution therapy at time of event. Smoking: Smokers were divided into current (smoking within a month) and past smokers. Lifetime history of migraine was classified according the International Headache Society (IHS) criteria. 12 Information on migraine was available for 968 (98.5%) CeAD patients and 653 (99.2%) non-CeAD IS patients of the CADISP population, included in the current study. Migraine type (migraine with aura [MA]/migraine without aura [MO]) was not defined for 22 patients.
Infection: An infection in the week preceding the dissection was defined by the presence of at least 1 typical symptom of infection, in combination with fever (temperature Ն38°C) or the presence of at least 1 typical symptom of infection with corresponding serologic, cultural, or radiologic findings indicating an acute infection or the combination of at least 2 typical corresponding symptoms. 13 A recent trauma was defined as physical impact on the head or neck (e.g., extreme neck movements, cervical manipulation, lifting up heavy loads) Ͻ1 month prior to the CeAD. If the trauma prompted a visit to a physician or hospitalization, the trauma was considered major. All other forms of traumas were considered mild.
Clinical and radiologic characteristics of CeAD patients. The following radiologic features at admission were recorded: arterial occlusion, stenosis, aneurysmal dilatation, and multiple dissections. Cervical pain and headache at the acute phase of CeAD and the occurrence of tinnitus and Horner syndrome were recorded.
Three-month outcome. Functional 3-month outcome was defined as favorable if mRS ϭ 0 -2 and excellent if mRS ϭ 0 -1. Major complications within 3 months included the following: stroke or TIA after admission, recurrent cervical artery dissection, intracranial hemorrhage, or major extracranial hemorrhage (i.e., leading to death, or requiring blood transfusion, surgery, or hospitalization). Putative risk factors and 3-month outcome were defined identically in CeAD and non-CeAD IS patients.
Statistical analyses. For comparisons between CeAD and
non-CeAD IS patients, only CeAD patients presenting with stroke were included (CeAD stroke , n ϭ 635) so that the groups would differ in one aspect only (i.e., etiology of stroke). All 968 CeAD patients were included in the comparisons between CeAD patients with or without migraine. The groups (CeAD stroke vs non-CeAD IS and CeAD patients with vs without migraine) were compared by using 2 , Mann-Whitney U, and t tests when appropriate. Thereafter, the comparisons were made by using logistic regression, adjusted for the following possible confounding factors: age, gender, country of inclusion, and prospective/retrospective recruitment. We additionally tested the results separately for prospective and retrospective patients, and this did not change the results (data not shown). Since CeAD and non-CeAD groups differ in terms of vascular risk factors, they were added as covariates to the comparisons regarding migraine and its subtypes. Since the frequency of migraine in women is higher than in men, 14 we performed additional analyses separately for both genders. Because of epidemiologic association of patent foramen ovale (PFO) and migraine, 15 a subgroup analysis of patients without PFO was run. The analyses were performed using PASW 18.0 for Windows. A 2-tailed value of p Ͻ 0.05 was considered statistically significant.
RESULTS

CeAD vs non-CeAD IS.
Demographic features and history of vascular risk factors in CeAD stroke and non-CeAD IS patients are shown in table 2. The majority of the 635 CeAD stroke patients (56.9%) were men. According to the TOAST classification, the cause of infarction in the non-CeAD IS group was large artery atherosclerosis in 86 (13.1%), cardioembolism in 239 (36.6%), small vessel disease in 44 (6.7%), other determined etiology in 19 (2.9%), and undetermined etiology in 265 (40.6%), of which 34 (5.2% of all IS patients) had multiple possible causes for stroke. All traditional vascular risk factors were less frequent in CeAD stroke patients compared to non-CeAD IS patients (table 2) .
Migraine characteristics of CeAD stroke vs non-CeAD IS groups. Migraine was more common in CeAD stroke patients (35.7 vs 27.4%, p ϭ 0.003). In terms of migraine subtypes, there was a higher frequency of MO in CeAD stroke compared to non-CeAD IS patients (20.2 vs 11.2%, p Ͻ 0.001), but the frequencies of MA were not different (13.1 vs 15.8%, p ϭ 0.322) (table 3). Migraine and migraine without aura were more common among CeAD stroke patients in both men and women, but after adjusting for . When all patients with PFO (n ϭ 197 non-CeAD IS and 36 CeAD stroke patients) were excluded from the analyses, and only patients in whom echocardiography was done were analyzed, the difference between CeAD stroke and non-CeAD IS groups regarding overall migraine was even clearer (37.8 vs 23.4, p Ͻ 0.001), but the difference in MA remained statistically insignificant (12.2 vs 12.4%, p ϭ 0.938).
CeAD patients with and without migraine. Migraine was twice more common in women than in men (213/422, 50.5% vs 128/546, 27.1%, p Ͻ 0.001). The comparisons of CeAD patients with and without migraine are presented in table 4. There was no difference between migraineurs and nonmigraineurs in terms of body mass index, hypertension, hypercholesterolemia, diabetes, smoking, admission NIHSS score, or prior minor trauma.
In the acute phase, migraineurs more often had headache (73.7% vs 63.2%, p ϭ 0.001). CeAD patients with ischemia (stroke or TIA) had as often migraine as patients with local signs only (36.9% vs 38.6%, p ϭ 0.650). On the other hand, CeAD pa-
and MO patients (63.4 and 60.7%, respectively, p ϭ 0.618). Nor was there difference between CeAD patients with and without migraine regarding the dissected vessel (ICA vs VA), vessel patency (occluded vs nonoccluded), presence of dissecting aneurysm, or the number of dissections (multiple vs single dissections). Presence or absence of migraine did not affect prognosis in CeAD patients in terms of favorable outcome (mRS 0 -2 in 85.8% in migraine group and 80.4% in nonmigraineurs) or complications. DISCUSSION We found that migraine, especially migraine without aura, is more common in CeAD patients than in non-CeAD ischemic stroke patients. As in the general population, 14 migraine was more common among women. The vascular risk factor profile was similar in CeAD patients with or without migraine. Migraine was not associated with cerebral ischemia in CeAD patients and did not influence the prognosis in CeAD.
It has been shown before that 1) patients with migraine, particularly MA, have increased risk of stroke, 5 2) CeAD patients have more migraine than non-CeAD ischemic stroke patients, 6, 16 and that 3) CeAD patients have more migraine than healthy controls. 4, 6, 16 The association between ischemic stroke and migraine is probably multifactorial. It may be related to increased frequency of some vascular risk factors among migraineurs, altered vascular reactivity, neurogenic inflammation, and excessive neuronal activation during migraine attacks, these changes being more pronounced in MA. 3, 17 In the light of our present data, it seems plausible that migraine accelerates or contributes to those pathogenetic processes that may lead to CeAD in otherwise susceptible patients. The fact that we observed no substantial difference in the frequency of migraine between CeAD patients with or without stroke indicates that the occurrence of stroke in CeAD patients is independent of migraine history. We could thus not confirm the findings of a previous study, 8 suggesting a lower prevalence of migraine among CeAD patients with stroke. Stroke in CeAD depends on the characteristics of the vessel wall damage, i.e., whether thromboembolism or significant hemodynamic changes occur or not. As hypothesized before, 6 1) patients with migraine might be at increased risk of extracellular matrix degradation, and subsequently increased risk of CeAD; 2) endotheliumdependent vasodilatation is impaired in both CeAD and migraine patients, suggesting that there could be a common generalized vascular disorder predisposing Abbreviations: CeAD stroke ϭ cervical artery dissection presenting with stroke; CI ϭ confidence interval; IS ϭ ischemic stroke; non-CeAD IS ϭ ischemic stroke without CeAD; MA ϭ migraine with aura; MO ϭ migraine without aura; OR ϭ odds ratio. a Logistic regression, adjusted for age, sex (first 3 lines), country of inclusion, prospective/ retrospective inclusion, hypertension, hypercholesterolemia, current smoking, diabetes mellitus, body mass index, and use of oral contraceptives or hormone replacement therapy in women. b Including subjects with pure MA and subjects with both MO and MA. c Significant.
to both conditions-the origin of this vasculopathy is likely multifactorial, resulting from a combination of genetic and environmental factors that remain to be discovered. 9, 18, 19 It has been unclear whether CeAD is linked to MA or MO or both. However, there were differences in the study designs and the control groups used in the different previous series (ischemic stroke controls and healthy controls), and each study involved patients of one nationality only. 4, 6, 16 The 2 latest casecontrol studies on migraine in CeAD, which partly overlap with the present study population, 4, 18 have the largest patient numbers. In a Finnish study, 4 CeAD patients were compared with healthy controls. Particularly MA was more common in CeAD patients than in healthy controls, and the association of MO and CeAD was parallel, but did not reach statistical significance. An Italian study 18 consisted of CeAD and non-CeAD IS patients and healthy controls. Compared with healthy controls, both MA and MO were more common in CeAD patients, whereas compared with the non-CeAD IS group, CeAD patients had more MO, not MA, which is consistent with our study. Furthermore, non-CeAD IS patients had more MA compared to healthy controls, 18 in line with literature on migraine and stroke. Considering Table 4 Differences between CeAD patients with or without migraine that our control group consists of patients who had an ischemic stroke, it is likely that MA is overrepresented in non-CeAD IS patients compared to healthy controls. This is likely to be one of the factors explaining why our CeAD patients did not differ from controls regarding MA. The following conclusions seem feasible based on the present and previous studies: 1) both MA and MO are more frequent in CeAD patients compared to healthy controls; 2) non-CeAD IS patients have more MA than healthy controls, but the rates of MO are similar; 3) CeAD patients have more MO than non-CeAD IS patients. There are conflicting results about the frequency of vascular risk factors in migraineurs compared to the general population. 17, 20, 21 In our study, CeAD patients with or without migraine did not differ in this aspect. Yet, it is known 22 that CeAD patients are a special subgroup in terms of vascular risk factors, as the frequency of hypercholesterolemia and body mass index are lower in CeAD patients compared to healthy controls. However, CeAD patients have more hypertension than the general population. It may be that migrainous CeAD patients represent a special subgroup also among migraineurs in terms of vascular risk factors.
Our results about the more frequent headache in the acute phase of CeAD in patients with migraine are consistent with a French study. 7 We could not verify the results of an earlier study, 23 indicating a higher prevalence of migraine in aneurysmal CeAD patients.
It should be noted that the distribution of TOAST categories in CADISP non-CeAD IS patients may not be representative of the distribution in the general stroke population. Some high-risk cardiac sources of embolism and other etiologies were not included by design so that patients with unknown stroke etiology may be overrepresented (table 2). Our non-CeAD patients are young adults (mean age 44.5). It was shown previously that in this age group the percentage of strokes with undetermined etiology is Ͼ30%, more than in older IS patients. 1, 24 Epidemiologic associations between PFO vs stroke and PFO vs migraine have been debated over the years with conflicting results. 15, 25 Non-CeAD IS patients in whom PFO was the only etiologic cause for stroke were overrepresented in our study due to recruitment criteria. Considering the possibility that our analyses could have been confounded by the non-CeAD patients with PFO, we performed a secondary analysis comparing CeAD and non-CeAD IS patients after excluding patients with PFO. PFO was indeed linked with migraine, especially MA. While our conclusion about the association between migraine and CeAD was unaffected by this subgroup analysis, PFO may explain some of the differences in the literature regarding MO/MA ratio, 6 and should be adjusted for in future research.
The strengths of the CADISP project are the large sample size and standardized collection of extensive clinical information in diverse populations. The limitations of our study include the following: our patients were recruited primarily in departments of neurology from tertiary academic centers, which may bias toward fewer CeAD patients with mild symptoms only. Patients with very severe strokes requiring intensive care were also less likely to be included. The lack of migraine data from healthy controls is of minor importance, since there are solid data showing that IS patients have more migraine than the general population. 5 This fact allows for the conclusion that CeAD patients also have more migraine than healthy controls. Both CeAD and non-CeAD IS patients were recruited retrospectively in part. There is no reason to assume that the potential recall bias concerning past migraine would be different among non-CeAD and CeAD patients. We did not correct for multiple testing.
Our study clearly verifies the association between migraine and CeAD which, compared with nonCeAD IS controls, was due to MO, while the mechanisms and possible causative link remain to be proved. We could not detect excess of brain infarction, specific arterial distribution, or other clinical or prognostic features characteristic to migrainous CeAD patients. Further studies exploring the mechanisms underlying the association between migraine and CeAD are warranted.
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